Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|September 16, 2024
Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCLYuxin Hong, Hehua Ma, Haoyi Yang, et al.
Pharmaceutical Biology|April 14, 2015
Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reactionHuilin Hu, Changlin Zhai, Gang Qian, et al.
Frontiers in Cell and Developmental Biology|June 27, 2024
Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic targetJunpeng Zhao, Dandan Jin, Mengxiang Huang, et al.
Journal of Cellular and Molecular Medicine|September 4, 2023
Differences between migrasome, a 'new organelle', and exosomeXuebing Xu, Tong Wu, Renjie Lin, et al.
Scientific Reports|January 3, 2025
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinomaHehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Peerj|June 27, 2020
Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysisDandan Jin, Yujie Jiao, Jie Ji, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2024
N6-methyladenosine (m6A) modification in hepatocellular carcinomaHehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Genes & Diseases|July 26, 2023
The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseasesMinxue Xu, Jie Ji, Dandan Jin, et al.
Genes & Diseases|November 11, 2024
Known and unknown: Exosome secretion in tumor microenvironment needs more explorationMengxiang Huang, Jie Ji, Xuebing Xu, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Lactylation: the regulatory code of cellular life activity and a barometer of diseasesXuebing Xu, Xuming Wu, Dandan Jin, et al.
Pageof 4